Last reviewed · How we verify
NCT04795570: STRICT-TURP
Urethral Stricture After Transurethral Resection of the Prostate/Bladder: a Prospective Study of Risk Factors
trial testing Transurethral resection of the prostate or bladder in Urethral Stricture, Male in 300 participants. Status unknown.
1 September 2021
Quick facts
| Lead sponsor | University Hospital Virgen de las Nieves |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 September 2020 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Transurethral resection of the prostate or bladder
Conditions studied
- Urethral Stricture, Male — all drugs for Urethral Stricture, Male →
- Hormone Deficiency — all drugs for Hormone Deficiency →
- Fibrosis — all drugs for Fibrosis →
Sponsor
University Hospital Virgen de las Nieves
Who can join
18 and older, male only, with Urethral Stricture, Male or Hormone Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is currently no prognostic or predictive risk marker for this urethral stricture disease. The most conservative standard treatment for urethral stricture (internal urethrotomy) has a very high recurrence rate (greater than 75%) and, on many occasions, reconstructive urologists have to choose within a great variety of further complex interventions. Knowing risk and predictive markers of this disease could help to optimize both the need and the approach for these surgeries and may offer a more individualized management to patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04795570
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urethral Stricture, Male
Currently open trials in the same condition.
- NCT05300685 — Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty · Phase 3 · recruiting
Other University Hospital Virgen de las Nieves trials
Trials by the same sponsor.
- NCT06518408 — A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV · active not recruiting
- NCT06765460 — Prescription of Exercise in Children · NA · completed
- NCT05044754 — SCAP vs HIFU for Recurrent Prostate Cancer After Radiation Therapy · unknown
- NCT04270773 — Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women · Phase 4 · active not recruiting
- NCT04232176 — Precision of Optical Diagnosis in Polyps Between 5-15 mm and Its Implications on Surveillance. A Prospective, Multicente · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04795570 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Virgen de las Nieves
- Last refreshed: 12 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04795570.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing